AMGN
Amgen Inc.
NasdaqGS
People also watch:BIIBGILDCELGMRKBMY
171.560.28 (0.16%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close171.28
Open171.57
Bid171.62 x 200
Ask171.66 x 400
52wk Range130.09 - 181.81
Day's Range170.54 - 171.92
Volume1,413,039
Avg Vol (3m)2,889,806
As of 1:09 PM EDT. NasdaqGS Real Time Price. Market open.
  • Forbes27 minutes ago

    Amgen's Drug Pipeline Fortifying A Biotech Pioneer

    Despite Amgen’s blockbuster patents nearing expiration, it has the potential to riposte with a competitive pipeline and drug profile.

  • Barrons.com1 hour ago

    Biotech Stocks: The End of Political Risk?

    RBC's Michael Yee and team contend that biotech stocks like Amgen (AMGN), Biogen (BIIB), Celgene (CELG), Gilead Sciences (GILD), and Alexion Pharmaceuticals (ALXN) are looking past the political risks: The SPDR S&P Biotech ETF (XBI) biotech index is up +13% in a month vs S&P500 +5% and we think political rhetoric and fear about drug pricing legislation which has been one of the primary overhangs on biotech stocks could be starting to move behind us as we go into H2:16. Indeed, given the large correction in the past year and rotation out of biotech, we think the market is starting to get more comfortable with the political environment and this could be an important shift and one of the key factors in driving stocks higher and removing the overhang.